Skip to search formSkip to main contentSkip to account menu

LY 353381

Known as: LY-353381, LY353381 
National Institutes of Health

Related topics

Related topics

4 relations

Narrower (2)

LY353381hydrochloridearzoxifene

Broader (2)

PiperidinesThiophenes

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2004
Review
2004
Selective oestrogen receptor modulators in desmoid tumours
Selective oestrogen receptor modulators (SERMs) are compounds with a mixed agonist/antagonist activity on oestrogen receptors. An… 
Highly Cited
2001
Highly Cited
2001
Analysis of cross-resistance of the selective estrogen receptor modulators arzoxifene (LY353381) and LY117018 in tamoxifen-stimulated breast cancer xenografts.
PURPOSE Cross-resistance is the primary issue facing the evaluation of new antiestrogens to treat metastatic breast cancer… 
Review
2001
Review
2001
Future use of selective estrogen receptor modulators and aromatase inhibitors.
Selective estrogen receptor modulators (SERMs) may act as estrogens or antiestrogens depending on the cell and tissue targets… 
2001
2001
Arzoxifene: (LY353381) A Novel Selective Estrogen Receptor Modulator with Activity in Breast Cancer
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)